ライフサイエンスコーパス: blood type

1 All patients were group A(1) blood type.

2 lood group antigens correlated strongly with blood type.

3 sified according to the candidates' race and blood type.

4 fter adjustment for study center and patient blood type.

5 onsecretor) rather than Le(a- b+) (secretor) blood type.

6 the alpha-Gal antigen, also correlated with blood type.

7 (6-14, 15-24, 25-29, 30-34, 35-40), age, and blood type.

8 1 (rs45458701) is responsible for the At(a-) blood type.

9 c.589+1G>C) and thus have the Augustine-null blood type.

10 tential blood substitute for the rare Bombay blood type.

11 nal creatinine greater than 1.5 mg/dL and AB blood type.

12 paper-based assay for the detection of human blood type.

13 orovirus infected humans regardless of A/B/O blood type.

14 binding proteins with erythrocytes from each blood type.

15 t or specific details regarding a particular blood type.

16 xicities in individuals with the rare Lan(-) blood type.

17 tested pretransfusion to determine the donor blood type.

18 endent markers, mitochondrial sequences, and blood type.

19 ast 10 days would not be possible with other blood types.

20 ess pronounced effect for infants with other blood types.

21 and specific microscale multiplex assay for blood typing.

22 ermatomyositis and some with polymyositis, a blood type 1 interferon-signature correlates with diseas

23 ers with blood group O than those with non-O blood types (10,353 g versus 3,555 g, P < 0.001).

24 AOR, 2.41 [95% CI, 1.24-4.70]); maternal AB blood type (4.9% stillbirths, 3.0% live births) (vs type

25 endogenous antibodies that react with human blood type A antigens in neurons.

26 Low Ccr at screening and blood type A are risk factors for IEC-defined CMV diseas

27 r alpha-D-GalNAc end groups and binds to the blood type A determinant GalNAcalpha1, as well as to ter

28 received a left single-lung allograft from a blood type A donor.

29 derived antibodies must be screened for anti-blood type A reactivity to avoid misidentification of vi

30 nsplantation with a blood group O donor to a blood type A recipient is described.

31 Transplantation of blood type A subgroup 2 (A2) livers into non-A recipient

32 Apparent VZV neuronal staining and blood type A were strongly associated (by a chi(2) test,

33 rons of the 30 to 40% of individuals who are blood type A.

34 and recipients for potential recipients with blood types A, B, and AB; and (2) all recipients who hav

35 iminating the payback system, and allocating blood type A2 and A2B kidneys to blood type B candidates

36 is approach, proof-of-concept ABO and D (Rh) blood typing and group A subtyping were successfully per

37 alysis showed that after adjusting for MELD, blood type, and diagnosis, patients listed in the latter

38 several noroviruses is linked to human histo-blood type, and its determinant histo-blood group antige

39 med according to donor blood type, recipient blood type, and transplant center ABOi volume.

40 he need for assist devices, nonidentical ABO blood types, and younger age.

41 YPA) and B (GYPB), which determine MN and Ss blood types, are two major receptors that are expressed

42 Using ABO blood typing as a proof-of-concept, we developed i) an i

43 We selected patients who underwent blood typing as potential live kidney donors for recipie

44 The concept of presenting a paper-based blood typing assay in a barcode-like pattern significant

45 Blood typing assay is a critical test to ensure the sero

46 These channels were then used to perform blood typing assays by introducing a blood sample.

47 allocating blood type A2 and A2B kidneys to blood type B candidates.

48 Immune tolerance to alpha-Gal in blood type B individuals might reduce the risk to this a

49 Because of a clerical error, a 67-year-old blood type B patient with idiopathic pulmonary fibrosis

50 new policy, candidates with a CPRA>20%, with blood type B, and aged 18-49 years were more likely to u

51 fied donation and transplantation across the blood-type barrier can increase transplants by 10% (PG0.

52 fied donation and transplantation across the blood-type barrier in kidney exchange.

53 dney donation and transplantation across the blood-type barrier in kidney exchange.

54 When compared with LTx candidates with other blood types, blood type O candidates have longer waiting

55 h donors to patients, not only with extended blood typing, but also by using genetically determined s

56 Predictors were age, sex, blood type, calculated panel-reactive antibodies, donati

57 Blood type can be visually identified from eluting lengt

58 or/recipient cytomegalovirus (CMV) status or blood type, cold ischemic times, or the incidence of out

59 Gender, age, ABO blood-type, cold ischemia, splenectomy and allograft typ

60 The SNP rs514659 (tags O blood type) contributed 15.4% of the variance.

61 Extended blood typing decreases alloimmunization in SCD but is no

62 atterns were associated with different histo-blood types, defined by Lewis, secretor, and ABO types.

63 nvestigated, only one pair with the same ABO blood type demonstrated identity at both alleles.

64 ced a barcode-like design into a paper-based blood typing device by integrating with smartphone-based

65 The proposed paper-based blood typing device is rapidly read by smartphones and e

66 etween participants adhering to a particular blood type diet (experimental group) and participants co

67 the evidence to support the effectiveness of blood type diets has not previously been assessed in the

68 ished studies that presented data related to blood type diets were identified and critically appraise

69 tudies that showed the health effects of ABO blood type diets were identified.

70 to validate the purported health benefits of blood type diets.

71 ing question: In humans grouped according to blood type, does adherence to a specific diet improve he

72 revious sternotomy (P = .0003), nonidentical blood type donor (P = .01), recipient non-blood group A

73 antigen expression, creating a risk for Vel blood typing errors and transfusion reactions.

74 d to donor variables including age, sex, ABO blood type, ethnicity, donor type and recipient variable

75 ability model estimated the total number and blood type frequencies of donor-recipient pairs that wou

76 s on erythrocyte membranes uniquely for each blood type, generating differential interactions of the

77 del with smoking, current smokers with non-O blood type had an adjusted OR of 2.68 (95% CI, 2.03-3.54

78 e activity measurements and calculated whole-blood type I IFN gene and chemokine scores.

79 Up-regulation of whole blood type I interferon (IFN)-driven transcripts and che

80 a live donor transplant due to crossmatch or blood type incompatibility.

81 issued immediately for patients in whom the blood type is known.

82 e the risk of waiting list death across era, blood types, liver disease diagnosis, and severity (Mode

83 truction of the transplant renal artery with blood type-matched iliac artery grafts should be conside

84 The authors have used preserved, blood type-matched, iliac artery grafts procured from ca

85 109 days) than the 399 candidates with other blood types (median 58 days) (P=0.001).

86 While current blood typing methods are well established, results are s

87 ells (RBCs, erythrocytes) means that careful blood-typing must be carried out prior to transfusion to

88 Patients with ABO blood type O and B have smaller chances.

89 n wait-list mortality; however, infants with blood type O assigned an ABO-I listing strategy were mor

90 with LTx candidates with other blood types, blood type O candidates have longer waiting times and hi

91 with the H-antigen trisaccharide from human blood type O erythrocytes, at 1.67 angstrom resolution.

92 There were more blood type O recipients than blood type O NDDs participating.

93 The 40 blood type O NDDs triggered a mean chain length of 6.0 (

94 Especially highly sensitized and blood type O patients benefit.

95 There were more blood type O recipients than blood type O NDDs participa

96 One hundred thirty-three blood type O recipients were transplanted.

97 n such exchanges to ensure that the standard blood type O wait-list candidates are made better off.

98 orally problematic because it harms standard blood type O wait-list candidates who already have the l

99 Compared with blood type O, the ORs for pancreatic cancer in subjects

100 lant (n = 90) was greater than the number of blood type O-non-directed donors (n = 32) initiating cha

101 The number of blood type O-patients receiving a transplant (n = 90) wa

102 5 transplants on average, more if the NDD is blood type O.

103 % CI, 2.03-3.54) compared with nonsmokers of blood type O.

104 The incidence rates for blood types O, A, AB, and B were 28.9, 39.9, 41.8, and 4

105 g participants by genotype-derived serologic blood type (O, A, AB, and B).

106 Subsequent blood typing of affected family members confirmed the po

107 t an advance for point of care applications, blood typing of newborns, and general blood assays in sm

108 luated the effects of age, race, gender, and blood type on anti-glycan antibody profiles in the serum

109 ntered in transfusions of patients with rare blood types or chronically transfused patients who becom

110 val were seen by donor blood type, recipient blood type, or transplant center ABOi volume.

111 risk of death by era of listing (P = .25) or blood type (P = .31), whereas the risk of death was sign

112 e assist devices (P = .02), nonidentical ABO blood types (P = .05), and younger age (P = .10).

113 ated more African Americans had incompatible blood types (P=0.01) or ineligible recipients (26.7% vs.

114 ted for recipient age, sex, race, ethnicity, blood type, panel reactive antibody, year of placement o

115 nicity, original disease, retransplants, ABO blood type, panel-reactive antibody, previous treatment,

116 ard diet (control group) within a particular blood type population.

117 A blood type rare in one country may not be considered rar

118 recipients were performed according to donor blood type, recipient blood type, and transplant center

119 o differences in survival were seen by donor blood type, recipient blood type, or transplant center A

120 , tumor doubling time, tumor growth pattern, blood type, regional transplant volume, initial tumor si

121 m and current panel reactive antibodies, ABO blood type, retransplants, pretreatment, time on dialysi

122 Although blood typing showed a very weak expression of Rh antigen

123 This paper presents a microfluidic blood typing system using a small quantity of blood samp

124 ential blood substitutes for the rare Bombay blood type that is characterized by a deficiency of H2 a

125 new, paper-based analytical device (PAD) for blood typing that allows for the simultaneous determinat

126 nded to include the 24,736 patients with any blood type, the results were similar, with rates of deat

127 n LDL-cholesterol responses of different MNS blood types to a low-fat diet.

128 itive hematopoiesis may produce many diverse blood types via a common multipotent progenitor, primiti

129 e population attributable fraction for non-O blood type was 19.5%.

130 ABO and Lewis blood typing was done for 38 women with RVVC (case-patie

131 ender, peak panel-reactive antibody, and ABO blood type were not found to be significant risk factors

132 Advantages with respect to the need for blood typing were balanced with various undesirable prop

133 ith A, B, and O secretors and Lewis positive blood types, were sensitive to the virus, while the non-

134 The exposure measure was ABO blood type, which is not inherently related to outcome,

135 The Augustine-negative alias At(a-) blood type, which seems to be restricted to people of Af

136 lf a century ago but remains one of the last blood types with no known genetic basis.